Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients

Background: Circulating tumor cells (CTC), androgen receptor full-length (AR-FL), and androgen receptor splice variant 7 (AR-V7) are prognostic in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). AR-V7 seems to predict resistance to androgen-receptor signaling inhibitors...

Full description

Bibliographic Details
Main Authors: Carlo Cattrini, Alessandra Rubagotti, Linda Zinoli, Luigi Cerbone, Elisa Zanardi, Matteo Capaia, Paola Barboro, Francesco Boccardo
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cancers
Subjects:
AR-V7
AR-FL
castration-resistant prostate cancer
prognostic biomarkers
circulating tumor cells
Online Access:https://www.mdpi.com/2072-6694/11/9/1365

Internet

https://www.mdpi.com/2072-6694/11/9/1365

Similar Items